VKH
IMUC.WS

Virtu KCG Holdings’s ImmunoCellular Therapeutics Ltd. IMUC.WS Stock Holding History

Virtu KCG Holdings’s Portfolio IMUC.WS Stock Details IMUC.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$0 Buy
+21,526
New +$3.76K ﹤0.01% 3803

Other funds holding IMUC.WS

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Virtu KCG Holdings's IMUC.WS Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in ImmunoCellular Therapeutics Ltd. (IMUC.WS) in Q2 2017: 21,526 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #3803 among its holdings.

5 funds tracked by Wall St. Rank hold IMUC.WS as of Q2 2017.

  • Virtu KCG Holdings held 21,526 shares of ImmunoCellular Therapeutics Ltd. worth $0 as of Q2 2017.
  • ImmunoCellular Therapeutics Ltd. was a new Virtu KCG Holdings position in Q2 2017.
  • ImmunoCellular Therapeutics Ltd. made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #3803 holding.
  • 5 funds tracked by Wall St. Rank held ImmunoCellular Therapeutics Ltd. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.